Characteristic upregulation of dopamine D-1-receptor in rat striatum after 6-hydroxydopamine treatment

被引:10
|
作者
Iwata, S
Shimizu, T
Nomoto, M
Fukuda, T
机构
[1] Department of Pharmacology, Faculty of Medicine
来源
JAPANESE JOURNAL OF PHARMACOLOGY | 1996年 / 71卷 / 03期
关键词
H-3]SCH23390; 6-hydroxydopamine; upregulation;
D O I
10.1254/jjp.71.255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We measured the number of D-1-receptors (B-max) in the striatum whose dopaminergic terminals were destroyed to various degrees by 6-hydroxydopamine (6-OHDA) to clarify the relationship between the degree of denervation and the change in B-max for D-1-receptor. Rats were sacrificed 28 days after 6-OHDA treatment, and [H-3]SCH23390 (R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) binding capacity and monoamine content were measured in striatal homogenate. B-max was significantly upregulated when dopamine content was reduced to less than 5% of that in the vehicle-treated striatum. In contrast, it was significantly decreased when dopamine content was 5-25% of that in the vehicle-treated striatum. The D-1-receptors showed either upregulation or downregulation depending on the degree of denervation.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 50 条
  • [1] D-1 RECEPTOR SUPERSENSITIVITY IN THE RAT STRIATUM AFTER UNILATERAL 6-HYDROXYDOPAMINE LESIONS
    BUONAMICI, M
    CACCIA, C
    CARPENTIERI, M
    PEGRASSI, L
    ROSSI, AC
    DICHIARA, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) : 347 - 348
  • [2] DEGENERATION OF THE NIGRAL DOPAMINE NEURONS AFTER 6-HYDROXYDOPAMINE INJECTION INTO THE RAT STRIATUM
    ICHITANI, Y
    OKAMURA, H
    MATSUMOTO, Y
    NAGATSU, I
    IBATA, Y
    BRAIN RESEARCH, 1991, 549 (02) : 350 - 353
  • [3] Dopamine receptor supersensitivity in rat subthalamus after 6-hydroxydopamine lesions
    Shen, KZ
    Zhu, ZT
    Munhall, A
    Johnson, SW
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (11) : 2967 - 2974
  • [4] Differential sensitivity of dopamine release and clearance to 6-hydroxydopamine lesioning in rat striatum
    Wang, Y
    Tang, FI
    Chiou, AL
    Wang, JY
    LIFE SCIENCES, 1996, 59 (21) : 1783 - 1792
  • [5] FAILURE TO DETECT 6-HYDROXYDOPAMINE IN RAT STRIATUM AFTER THE DOPAMINE RELEASING DRUGS DEXAMPHETAMINE, METHYLAMPHETAMINE AND MPTP
    ROLLEMA, H
    DEVRIES, JB
    WESTERINK, BHC
    VANPUTTEN, FMS
    HORN, AS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 132 (01) : 65 - 69
  • [6] EFFECT OF DOPAMINE D-1-RECEPTOR AND D-2-RECEPTOR SELECTIVE DRUGS ON DOPAMINE RELEASE AND METABOLISM IN RAT STRIATUM INVIVO
    ZETTERSTROM, T
    SHARP, T
    UNGERSTEDT, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 334 (02) : 117 - 124
  • [7] 6-hydroxydopamine lesions of the striatum lead to the alterations of dopamine receptor mRNA in parkinsonian rats
    Mladenovic, A
    Perovic, M
    Milanovic, D
    Kanazir, S
    Rakic, L
    Ruzdijic, S
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2002, 21 (03): : 275 - 282
  • [8] Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine
    S. Dethy
    M. A. Laute
    P. Damhaut
    S. Goldman
    Journal of Neural Transmission, 1999, 106 : 145 - 158
  • [9] Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine
    Dethy, S
    Laute, MA
    Damhaut, P
    Goldman, S
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (02) : 145 - 158
  • [10] CORRELATION OF FUNCTIONAL RECOVERY AFTER A 6-HYDROXYDOPAMINE LESION WITH SURVIVAL OF GRAFTED FETAL NEURONS AND RELEASE OF DOPAMINE IN THE STRIATUM OF THE RAT
    RIOUX, L
    GAUDIN, DP
    BUI, LK
    GREGOIRE, L
    DIPAOLO, T
    BEDARD, PJ
    NEUROSCIENCE, 1991, 40 (01) : 123 - 131